Open access
Open access
Powered by Google Translator Translator

Arrhythmias/Electrophysiology

Subepicardial Cardiomyopathy: a disease underlying J-wave syndromes and idiopathic ventricular fibrillation

29 May, 2023 | 10:38h | UTC

Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation – Circulation

 

Commentary on Twitter

 


Consensus Statement | Management of arrhythmias during pregnancy

23 May, 2023 | 13:00h | UTC

2023 HRS Expert Consensus Statement on the Management of Arrhythmias During Pregnancy – Heart Rhythm

News Release: Management of Arrhythmias During Pregnancy Consensus Statement Emphasizes Shared Decision-Making – European Heart Rhythm

 


Consensus Statement | Practical management of the remote device clinic

23 May, 2023 | 12:58h | UTC

2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic – Heart Rhythm

 


Guideline | Cardiac physiologic pacing for the avoidance and mitigation of heart failure

23 May, 2023 | 12:55h | UTC

2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure – Heart Rhythm

News Release: New clinical practice guideline on cardiac physiological pacing – Elsevier

 


Atrial fibrillation incidence associated with exposure to anticancer drugs used as monotherapy in clinical trials

10 May, 2023 | 15:54h | UTC

Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials – JACC: CardioOncology

Editorials:

Atrial Fibrillation With Modern Cancer Treatment: More Common Than We Think – JACC: CardioOncology

Atrial Fibrillation in Patients With Cancer: A Persistent and Increasing Challenge – JACC: CardioOncology

 

Commentary on Twitter

 


Review | Causes of sudden death

9 May, 2023 | 14:16h | UTC

Causes of sudden death – European Heart Journal Supplements

See all articles in the series here

 


Review | The bidirectional association between atrial fibrillation and myocardial infarction

8 May, 2023 | 12:54h | UTC

The bidirectional association between atrial fibrillation and myocardial infarction – Nature Reviews Cardiology (if the link is paywalled, try this one)

 

Commentary on Twitter

 


M-A | Direct oral anticoagulants versus warfarin across the spectrum of kidney function in patients with AF

3 May, 2023 | 15:32h | UTC

Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF – Circulation (free for a limited period)

 

Commentary on Twitter

 


Oral anticoagulation in patients with advanced CKD and atrial fibrillation: beyond anticoagulation

2 May, 2023 | 13:20h | UTC

Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation – Mayo Clinic Proceedings

 


RCT | Comparison of three different substrate ablation strategies for persistent atrial fibrillation

26 Apr, 2023 | 14:18h | UTC

Multi-centre, prospective randomized comparison of three different substrate ablation strategies for persistent atrial fibrillation – EP Europace

 


RCT | No difference in atrial fibrillation recurrence with early vs. delayed AF ablation at 12 months

24 Apr, 2023 | 13:49h | UTC

Impact of Early Versus Delayed Atrial Fibrillation Catheter Ablation on Atrial Arrhythmia Recurrences – European Heart Journal (link to abstract – $ for full-text. Free PDF may be available here)

 

Commentary on Twitter

 


Global Survey | Incidence, management and prognosis of esophageal fistula after atrial fibrillation catheter ablation

19 Apr, 2023 | 13:14h | UTC

A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study – European Heart Journal

Commentary: Esophageal Fistula Still a Rare but Deadly Complication of AF Ablation: POTTER-AF – TCTMD

 

Commentary from the author on Twitter

 


EHRA expert consensus document on the management of arrhythmias in frailty syndrome

18 Apr, 2023 | 12:58h | UTC

EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) – EP Europace

 


Cohort Study | Value of screening for the risk of sudden cardiac death in young competitive athletes

12 Apr, 2023 | 13:11h | UTC

Value of screening for the risk of sudden cardiac death in young competitive athletes – European Heart Journal

Editorial: Optimizing pre-participation screening to prevent tragedy in young athletes: moving from if to how – European Heart Journal

 


RCT | Augmented ablation fails to outperform standard ablation in paroxysmal AF patients

11 Apr, 2023 | 13:57h | UTC

Standard vs Augmented Ablation of Paroxysmal Atrial Fibrillation for Reduction of Atrial Fibrillation Recurrence: The AWARE Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)

Commentary: Augmented Ablation Adds No Benefit in Prevention of Recurrent Atrial Arrhythmia – HCP Live

 

Commentary on Twitter

 


Study identifies top 3 anticancer drugs with highest atrial fibrillation rates

11 Apr, 2023 | 13:55h | UTC

Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials – JACC: CardioOncology

Commentary: More AF Surveillance Needed in Chemotherapy Trials, Meta-analysis Hints – TCTMD

 


Adolescent sudden cardiac death: the role of underlying conditions and physical activity

5 Apr, 2023 | 13:26h | UTC

Sudden Cardiac Death Among Adolescents in the United Kingdom – Journal of the American College of Cardiology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


SCAI/HRS Expert consensus statement on transcatheter left atrial appendage closure

31 Mar, 2023 | 13:44h | UTC

SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure – JSCAI

Key Points: Consensus Statement on Transcatheter LA Appendage Closure – American College of Cardiology

Commentaries:

SCAI/HRS Consensus Document Covers the Ins and Outs of LAAO – TCTMD

New SCAI/HRS Expert Consensus Statement Addresses Transcatheter LAAC – American College of Cardiology

 


Coffee consumption vs. caffeine avoidance: cardiac ectopy, daily steps, and sleep impacts

27 Mar, 2023 | 13:32h | UTC

Summary: A prospective, randomized, case-crossover trial studied the acute health effects of caffeinated coffee consumption in 100 ambulatory adults.

Participants were monitored using continuous electrocardiogram devices, wrist-mounted accelerometers, and ongoing glucose monitoring systems for 14 days. They received daily text messages instructing them to either consume caffeinated coffee or abstain from caffeine.

The primary outcome was the mean number of daily premature atrial contractions. Results indicated that caffeinated coffee consumption didn’t lead to significantly more daily premature atrial contractions compared to caffeine avoidance. However, it was associated with a higher number of daily premature ventricular contractions, increased daily steps, and reduced nightly sleep.

Article: Acute Effects of Coffee Consumption on Health among Ambulatory Adults – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

What to know about new research on coffee and heart risks – Associated Press

CRAVE Trials Offers Most Comprehensive Overview Yet of Impact of Coffee, Caffeine Intake – HCP Live

Acute Effects of Coffee Consumption on Health – American College of Cardiology

 


BRAVO Registry | Brugada substrate ablation results in a significant reduction of ventricular fibrillation events

27 Mar, 2023 | 13:11h | UTC

Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry) – Circulation (free for a limited period)

 


Study shows increased bleeding complications in ESKD patients undergoing AF ablation

24 Mar, 2023 | 13:09h | UTC

Summary: The study analyzed 347 procedures in 307 patients with end-stage kidney disease (ESKD) undergoing atrial fibrillation (AF) catheter ablation in 12 referral centers in Japan.

Despite a vast majority of patients having subtherapeutic international normalized ratio (INR) values during the peri-procedural period, 35 patients (10%) experienced major complications, with the majority being major bleeding events (19 patients; 5.4%), including 11 cases of cardiac tamponade (3.2%). There were also two peri-procedural deaths (0.6%), both related to bleeding events. A pre-procedural INR value of 2.0 or higher was identified as the only independent predictor of major bleeding.

Current peri-procedural anticoagulation guidelines state that patients undergoing AF ablation should be under therapeutic anticoagulation throughout the peri-procedural period. The findings of this study suggest that these guidelines may not be appropriate for ESKD patients undergoing the procedure, and the role of peri-procedural anticoagulation in this population should be further investigated.

Article: Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease–atrial fibrillation ablation registry – EP Europace

 

Commentary on Twitter

 


M-A | Posterior pericardiotomy reduces the risk of atrial fibrillation after cardiac surgery

22 Mar, 2023 | 13:18h | UTC

Posterior pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: a systematic review and meta-analysis of 25 randomised controlled trials – EuroIntervention (link to abstract – $ for full-text)

Related:

Effect of posterior pericardiotomy in cardiac surgery: A systematic review and meta-analysis of randomized controlled trials – Frontiers in Cardiovascular Medicine

The Role of the Posterior Left Pericardiotomy in Reducing Pericardial Effusion and Postoperative Atrial Fibrillation After Cardiac Surgery – American College of Cardiology

Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial – The Lancet

 


SR | Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation

20 Mar, 2023 | 13:41h | UTC

Summary: This systematic review and meta-analysis assessed the efficacy of Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation (AF). The review included nine randomized controlled trials involving 3,269 participants.

The analysis found that Class I and/or III antiarrhythmic drugs may reduce the recurrence of atrial tachyarrhythmias at 0 to 3 months and likely reduce recurrence at > 3 to 6 months. However, beyond six months, the evidence is uncertain, and the benefit of antiarrhythmic drugs may not persist. Additionally, the use of these drugs post-ablation likely reduces hospitalizations for atrial tachyarrhythmias by approximately 57% at 0 to 3 months.

The use of Class I and/or III antiarrhythmic drugs did not increase the risk of thromboembolic events, myocardial infarction, all-cause mortality, or the need for repeat ablation.

Article: Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation – Cochrane Library

Summary: Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation – Cochrane Library

 


AHA Scientific Statement | Atrial fibrillation occurring during acute hospitalization

14 Mar, 2023 | 14:04h | UTC

Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association – Circulation

 


Review | Orthostatic tachycardia after covid-19

14 Mar, 2023 | 13:48h | UTC

Orthostatic tachycardia after covid-19 – The BMJ

Commentary: Key steps for diagnosis and management of orthostatic tachycardia after COVID-19 – News Medical

 


Stay Updated in Your Specialty

No spam, just news.